艾媒咨询 | 2026-2027年中国医疗美容产业发展与消费趋势报告

作为消费升级与“颜值经济”深化发展的重要赛道，医疗美容产业持续受益于生物材料、光电技术及数字化平台对产品研发、精准营销、服务交付与术后管理等环节的全方位赋能，其效能已从单一的非手术类项目延伸至再生医学、抗衰老管理与轻医美连锁化运营等场景革新。当前，行业版图内上游药械制造、中游医疗服务、下游互联网平台及供应链服务等多元模式竞合交织，机构对医生资源、合规产品与用户口碑的争夺日趋白热化，监管框架从专项整治向常态化、精细化规范演进，安全与合规成为竞争底线。在政策端，促进医疗健康消费、规范医美行业发展及支持生物医药与高端医疗器械创新的信号持续释放，为医疗美容企业在产品研发、模式创新及品牌建设中注入了新的活力。纵观行业发展脉络，医疗美容产业正经历从营销驱动向产品力与品牌价值创造的跃迁，材料创新与医疗服务标准化的广度深度将成为进一步发展的关键支点。
全球领先的新经济产业第三方数据挖掘和分析机构iiMedia Research（艾媒咨询）最新发布的《2026-2027年中国医疗美容产业发展与消费趋势报告》数据显示，医疗美容产业高度集中于以长三角为核心的经济发达与消费活跃地带，既折射出区域间在消费能力、医生人才、机构密度及监管执行等方面的深层差异，也催生了特色化、差异化的区域医美消费板块。头部企业在市值、营收和利润方面都占据优势，TOP10营收集中度较高，前三名营收占比达74.63%，整体行业营收结构呈现少数龙头企业领跑、中小企业差异化竞争的格局。其中聚焦功能性护肤品和医美手术的企业发展较快，反映出行业从规模化向精细化转型阶段。
通过对典型企业的研究，可以更直观地了解医疗美容板块各具特色的布局和差异化的发展路径。华熙生物以其在透明质酸原料、功能性护肤品及医美终端产品上的全产业链布局，展现了生物活性材料研发与品牌化运营协同的路径；爱美客作为注射填充类医美产品龙头，其经营情况与估值波动深度绑定于合规产品放量及再生材料等新品获批节奏，研发投入与渠道管控能力对其持续成长构成了关键支撑；朗姿股份作为医美服务连锁布局的代表，凭借旗下医美机构品牌在轻医美及手术类项目上的区域深耕，实现了从时尚消费向医疗美容服务的跨界协同发展。三家企业的资产结构、盈利质量与估值逻辑虽有差异，但共同指向了精细化运营、持续创新与医疗安全及服务价值的深度挖掘。
As a key sector driving the ongoing evolution of consumption upgrading and the "Aesthetic Economy," the medical aesthetics industry continues to benefit from the comprehensive empowerment provided by biomaterials, optoelectronic technologies, and digital platforms across various stages—including product development, precision marketing, service delivery, and post-procedure management. Its scope has expanded beyond standalone non-surgical procedures to encompass innovative applications such as regenerative medicine, anti-aging management, and the chain-based operation of light aesthetic treatments. Currently, the industry landscape features a complex interplay of competitive and collaborative dynamics across diverse business models—ranging from upstream pharmaceutical and medical device manufacturing to midstream healthcare services and downstream internet platforms and supply chain services. Competition among institutions for physician resources, compliant products, and customer reputation has intensified significantly; meanwhile, the regulatory framework has evolved from targeted Special Rectification Campaign initiatives toward more normalization and refined standardization, with safety and compliance becoming the baseline for competitive advantage. On the policy front, ongoing signals aimed at stimulating healthcare and wellness consumption, regulating the medical aesthetics industry, and supporting innovation in biopharmaceuticals and high-end medical devices have injected new vitality into medical aesthetics enterprises' efforts in product development, business model innovation, and brand building. Overall, the medical aesthetics industry is undergoing a transformative shift—from being marketing-driven to focusing on the creation of product competitiveness and brand value; in this context, material innovation and the standardization of healthcare services—both in breadth and depth—will serve as pivotal leverage points for further growth.
According to the latest "2026–2027 China Medical Cosmetology Industry Development and Consumption Trend Report" released by iiMedia Research, a globally leading third-party data mining and analysis firm specializing in the new economy sector, the medical cosmetology industry is highly concentrated in economically developed and consumer-active regions, particularly around the Yangtze River Delta. This concentration not only reflects deep-seated regional disparities in consumer purchasing power, physician talent pool, institutional density, and regulatory enforcement but has also given rise to specialized and differentiated regional medical cosmetology consumption segments. Leading enterprises hold advantages in terms of market capitalization, revenue, and profitability; the top 10 companies account for a high concentration of total revenue, with the top three companies representing 74.63% of the industry's total revenue. The overall industry revenue structure features a landscape where a few leading enterprises drive growth, while small and medium-sized enterprises engage in differentiated competition. Among these, companies focusing on functional skincare products and medical cosmetic procedures are experiencing rapid growth, reflecting the industry's transition from a scale-driven model to a precision-driven one.
By studying representative enterprises, one can gain a more intuitive understanding of the distinctive strategic layouts and differentiated development pathways within the medical cosmetology sector. Huaxi Biotech demonstrates a synergistic approach to the R&D of bioactive materials and brand-driven operations through its comprehensive industrial chain layout covering hyaluronic acid raw materials, functional skincare products, and medical aesthetics end-products; Aimeike, as a leading player in injectable filling-based medical aesthetics products, sees its operational performance and valuation fluctuations closely tied to the pace of mass-market adoption of compliant products and the approval timeline for new products such as regenerative materials; its R&D investment and channel management capabilities serve as key supports for its sustainable growth; Langzi Co., Ltd., representing a company with a strategic chain-based medical aesthetics service network, has achieved cross-sector synergistic development—shifting from fashion-oriented consumer goods to medical aesthetics services—through its regional deepening of operations across light medical aesthetics and surgical procedures under its medical aesthetics institution brands. Although these three companies differ in their asset structures, profit quality, and valuation logic, they collectively point to refined operational practices, continuous innovation, and the deep exploration of medical safety and service value.

艾媒咨询 | 2025年中国医美行业发展状况与消费行为调查数据

随着消费升级与技术迭代，中国医美行业已从传统整形扩展至轻医美、抗衰老等多元化领域，市场规模持续扩大。根据全球领先的新经济产业第三方数据挖掘和分析机构iiMedia Research（艾媒咨询）最新发布的《2025年中国医美行业发展状况与消费行为调查数据》显示，2025年中国医美服务行业市场规模为3701亿元，2025年中国轻医美市场用户规模达3105万人。中国医美市场的增长不仅源于消费升级，也得益于技术普惠与轻医美项目的高复购率。当前行业已进入以精细化运营、差异化服务和合规化发展为核心驱动的新阶段。
在2025年中国消费者对医美项目的接受程度中，“会考虑整形，但风险要相对可控”位列第一，占比46.02%；其次是“能够接受手术医美整形，并承受一定风险”，占比22.94%。此外，在消费者接受过的医美项目中，轻医美（非手术类）占比最高，达到74.45%；医美整形（手术类）的占比为33.52%。这表明中国消费者对医美的态度趋于理性与谨慎，安全可控的非手术类项目成为市场主流偏好。同时，手术类项目亦拥有稳定的需求群体，显示出市场需求的层次性与多元化。
艾媒咨询分析师认为，未来中国医美市场将延续“轻医美主导、技术驱动、合规深化”的主线发展。一方面，非手术项目凭借低风险、高复购优势，仍是增长核心，Z世代与男性、下沉市场需求进一步释放。另一方面，再生材料、AI个性化方案及智能器械加速迭代，推动服务精准化与效果革新。此外，监管常态化下，行业加速品牌化整合，合规机构与上游技术型企业凸显优势。总的来说，消费者更趋理性，追求自然效果与安全保障，倒逼市场从营销竞争转向以品质、精细化运营为核心的高质量发展新阶段。
With the upgrading of consumption and technological advancements, China's medical aesthetics industry has expanded from traditional plastic surgery to diversified fields such as minimally invasive aesthetics and anti-aging. The market size has continued to grow. According to the latest "2025 China Medical Aesthetics Industry Development Status and Consumer Behavior Survey Data" released by iiMedia Research, a leading third-party data mining and analysis institution for the new economy industry, the market size of China's medical aesthetics service industry will reach 370.1 billion yuan in 2025, and the user scale of the minimally invasive aesthetics market in China will reach 31.05 million people in 2025. The growth of China's medical aesthetics market is not only due to the upgrading of consumption but also benefits from the popularization of technology and the high repurchase rate of minimally invasive aesthetics projects. Currently, the industry has entered a new stage driven by refined operation, differentiated services, and compliance development.
In terms of Chinese consumers' acceptance of medical aesthetics projects in 2025, "Would consider plastic surgery, but the risk should be relatively controllable" ranks first, accounting for 46.02%; followed by "Can accept surgical medical aesthetics and bear certain risks", accounting for 22.94%. Additionally, among the medical aesthetics projects consumers have received, minimally invasive aesthetics (non-surgical) accounts for the highest proportion, reaching 74.45%; surgical medical aesthetics accounts for 33.52%. This indicates that Chinese consumers' attitudes towards medical aesthetics are becoming more rational and cautious, and non-surgical projects with low risks and high repurchase rates have become the mainstream preference in the market. At the same time, surgical projects also have a stable demand group, demonstrating the hierarchical and diversified nature of market demand.
Analysts from iiMedia Research believe that in the future, China's medical aesthetics market will continue to develop along the main line of "minimally invasive aesthetics dominance, technology-driven, and compliance deepening". On the one hand, non-surgical projects, with their low-risk and high-repurchase advantages, will remain the core of growth, and the demands of Generation Z, men, and consumers in lower-tier cities will be further released. On the other hand, regenerative materials, AI personalized solutions, and intelligent devices will accelerate iteration, promoting the precision and effect innovation of services. Moreover, under the normalization of regulation, the industry will accelerate brand integration, and compliant institutions and upstream technology enterprises will highlight their advantages. In summary, consumers are becoming more rational, pursuing natural effects and safety guarantees, which will force the market to shift from marketing competition to high-quality development centered on quality and refined operation.

2024-2027年中国互联网+美容美发行业发展研究

艾媒咨询研究院深入调研相关企业以及投资人士，结合国内外案例，依据艾媒北极星监测系统、草莓派用户调研中心的相关数据和预测模型，对行业的未来发展进行深度洞悉，推出了《2024-2027年中国互联网+美容美发行业发展研究》。报告对行业区域发展、企业经营、行业竞争格局等进行了重点分析，最后分析了行业的发展趋势并提出投融资建议。本报告数据权威、详实、丰富，同时通过专业的分析预测模型，对行业核心发展指标进行科学地预测。

艾媒咨询 | 2024年中国家用美容仪行业消费者洞察研究报告

随着居民收入水平提高，中国医美市场规模持续快速发展，进而带动了家用美容仪市场的消费升级。与此同时，家用美容仪逐渐被纳入更严格的医疗器械监管，促进了市场良好有序地发展，共同推动了市场的消费升级。中国家用美容仪市场伴随着国产品牌的快速成长，国产品牌占有的市场份额将进一步扩大。为了保障消费者权益，国家药监局加大了对家用美容仪，特别是射频美容仪的监管力度。在监管趋严的背景下，企业更应注重技术创新和产品研发，生产符合国家标准的家用美容仪产品，保障行业健康有序高质量发展。随着监管政策的推出，行业呈现高质量发展态势，市场规模有望持续增长。
As residents' income levels have increased, the Chinese medical aesthetics market has continued to experience rapid growth, thereby driving the upgrading of consumption in the home beauty instrument market. At the same time, home beauty instrument is gradually included in the stricter regulation of medical devices, which promotes the good and orderly development of the market, and jointly promotes the consumption upgrade of the market. China's domestic beauty instrument market is accompanied by the rapid growth of national brands, and the market share occupied by national brands will be further expanded. In order to protect consumer rights and interests, the State Drug Administration has increased the regulation of home beauty equipment, especially radio frequency beauty equipment. Under the background of tightening regulation, enterprises should pay more attention to technological innovation and product research and development, production of household beauty instrument products in line with national standards, to protect the industry's healthy and orderly high-quality development. With the introduction of regulatory policies, the industry presents a high-quality development trend, the market size is expected to continue to grow.

艾媒咨询｜2021年中国美容美发行业投资机遇及总体趋势研究报告

数据显示，2015-2021年中国美容美发行业市场规模复合增长率为4.0%，2021年市场规模为3863亿元。随着国民生活水平的提高以及对生活品质的不断追求，美容美发业的消费需求旺盛，上下游产业和新兴业态快速发展，预估2022年中国美容美发行业市场规模将突破4000亿元。且值得注意的是，在备案完善、监督加强及违法经营成本提升的背景下，中国化妆品行业将加速整顿，有效保障产品安全及其功效的稳定性，具有较强研发实力的品牌有望占据更大的市场份额。随着新消费群体逐渐成为购买主力，不能快速响应市场的品牌面临淘汰，大规模企业兼并即将到来。
According to the data, the compound growth rate of the market scale of China's beauty salon industry from 2015 to 2021 was 4.0%, and the market scale in 2021 was 386.3 billion yuan. With the improvement of national living standards and the continuous pursuit of quality of life, the consumption demand of beauty salon industry is strong, and the upstream and downstream industries and emerging business forms are developing rapidly. It is estimated that the market scale of China's beauty salon industry will exceed 400 billion yuan in 2022. It is worth noting that under the background of perfect filing, strengthened supervision and increased illegal operating costs, China's cosmetics industry will accelerate the rectification and effectively ensure the stability of product safety and efficacy. Brands with strong R & D strength are expected to occupy a larger market share. As new consumer groups gradually become the main force of purchase, brands that cannot respond quickly to the market are facing elimination, and large-scale enterprise mergers are coming.

艾媒咨询|2021年中国医美机构市场竞争态势及企业营销模式分析报告

本报告研究涉及企业/品牌/案例：华韩整形，瑞丽医美，美莱整形，医思健康

数据显示，2016—2020年中国医美行业市场规模五年平均增长率为12.8%，与此同时，中国医美市场用户规模增长了4倍多。在人们生活水平的提升、年轻一代对医美的接受度的提高、政府监管层对医美行业的整治给医美消费者信心的提升的综合作用下，预计中国医美市场规模在2022年将达到2232亿元。随着医美产品及仪器技术水平提升、医美知识普及等，民众对整形美容的观念正在向积极态度转变，在整个行业扩张的过程中，轻医美的受众面广、门槛低、复购率高，更有可能提升市场整体渗透率，成为我国医美行业的主要增量市场。
According to the data, from 2016 to 2020, the five-year average growth rate of the market scale of China's medical and American industry was 12.8%. At the same time, the user scale of China's medical and American market increased by more than four times. Under the combined effect of the improvement of people's living standards, the improvement of the acceptance of medical beauty by the younger generation, the regulation of the medical beauty industry by the government regulators and the improvement of medical beauty consumer confidence, it is expected that the scale of China's medical beauty market will reach 223.2 billion yuan in 2022. With the improvement of the technical level of medical beauty products and instruments and the popularization of medical beauty knowledge, people's concept of plastic beauty is changing to a positive attitude. In the process of the expansion of the whole industry, light medical beauty has a wide audience, low threshold and high repurchase rate, which is more likely to improve the overall penetration rate of the market and become the main incremental market of China's medical beauty industry.

艾媒咨询|2021年中国轻医美行业研究及产业链分析报告

本报告研究涉及企业/品牌/案例：爱美客，华熙生物，奇致激光，华韩整形，新氧，兰州生物

数据显示，2020年中国轻医美用户市场规模达到1520万人，预计到2021年将增至1813万人。在消费意识觉醒和消费需求驱动下，机构、医生在供给端强势助推轻医美行业更快速发展，预计2021年中国轻医美市场将达到798亿元，同比增长46.4%。在行业快速增长的同时，轻医美产业链各环节企业由于集中度不同导致利润分配不均，具体来看，上游原料耗材企业由于高技术壁垒，市场集中度较高，毛利率高于中下游企业，如知名玻尿酸、肉毒素产品制造企业爱美客、华熙生物等，而中下游由于竞争分散，单体获利参差不齐，更容易产生乱象。但总体来说，在行业监管加强、机构自律、平台监督等多方力量共同作用下，轻医美行业将会向线上化、品牌化、规范化发展。
According to the data, the market size of China's light medical beauty users will reach 15.2 million in 2020, and it is expected to increase to 18.13 million by 2021. Driven by the awakening of consumer awareness and consumer demand, institutions and doctors strongly boost the rapid development of light medical beauty industry in the supply side. It is estimated that China's light medical beauty market will reach 79.8 billion yuan in 2021, with a year-on-year growth of 46.4%. With the rapid growth of the industry, the profit distribution of enterprises in each link of the light medical beauty industry chain is uneven due to different concentration. Specifically, due to high technical barriers, the upstream raw materials and consumables enterprises have higher market concentration and higher gross profit rate than the middle and downstream enterprises, such as the well-known hyaluronic acid, botulinum toxin product manufacturing enterprises aimekke, Huaxi biology, etc., while the middle and downstream enterprises have higher gross profit rate due to scattered competition, Individual profit is uneven, more likely to produce chaos. But on the whole, under the joint action of industry supervision, institutional self-discipline, platform supervision and other forces, the light medical beauty industry will develop to online, brand and standardization.

艾媒咨询|2020上半年中国医疗美容行业趋势研究报告

本报告研究涉及企业/品牌/案例：美团医美、新氧。

受颜值经济影响，医疗美容市场异常火热，自2013年以来，中国医疗美容市场规模便保持持续增长趋势，预计2020年中国医疗美容用户规模达1520万人。随着医美消费意识的进一步觉醒、供给的持续增长和“互联网+医美”模式的渗透，未来医美行业的用户规模将继续增长。iiMedia Research（艾媒咨询）调研数据显示，六成用户理解支持医美消费，而目前线下医美机构仍然是消费者获取医美信息的主要渠道，其次是网络社交平台以及互联网医美平台。互联网医美平台的渗透率提升及内容化趋势，将有效推动行业资源的进一步整合，专业医美平台未来或将成为消费者了解及鉴别医美信息的重要窗口。美团医美、新氧等互联网医疗美容平台为医美行业新生态建设起到推动作用。互联网医疗美容平台的出现，以其低廉的佣金和可靠的垂直搜索特性在一定程度上帮助医美行业吸引更多消费者，拓展了获客渠道。未来医美机构将更加注重调整自身的营销策略，借助互联网平台等新手段更加精准的进行用户挖掘和服务扩散。

Affected by the beauty economy, the medical beauty market is extremely hot. Since 2013, the size of China's medical beauty market has maintained a continuous growth trend. It is estimated that the number of Chinese medical beauty users will reach 15.2 million in 2020. With the further awakening of medical aesthetics consumption awareness, continuous growth in supply and the penetration of the "Internet and medical aesthetics" model, the user scale of the medical aesthetics industry will continue to grow in the future. As the data of iiMedia Research showed, Sixty percent of users understand that they support the consumption of medical beauty, and offline medical beauty institutions are still the main channels for consumers to obtain medical beauty information, followed by online social platforms and Internet medical beauty platforms. The penetration rate and content trend of Internet medical aesthetics platforms will effectively promote the further integration of industry resources. In the future, professional medical aesthetics platforms may become an important window for consumers to understand and identify medical aesthetics information. Internet medical cosmetology platforms such as Meituan Medical Beauty and So Young have played a role in promoting the construction of a new ecology in the medical cosmetology industry. The emergence of the Internet medical cosmetology platform, with its low commissions and reliable vertical search features, has helped the medical cosmetology industry to attract more consumers to a certain extent and expanded the customer acquisition channels. In the future, medical aesthetic institutions will pay more attention to adjusting their own marketing strategies, and accurately conduct user data mining and service diffusion.

艾媒舆情|2020年315晚会“可诺丹婷虚假广告”问题曝光舆情监测报告

2020年7月16日，央视在3·15晚会曝光了可诺丹婷美容院存在以“免费”噱头推销高价美容项目、以“连环计”设套诱导学生消费、以格式条款及其他借口拒绝消费者退款等涉嫌违法行为。当晚，可诺丹婷美容院发表声明称，已立即要求涉事门店停业整顿，并已成立专项工作小组跟进此事。

艾媒报告|2019年中国轻医美消费趋势研究报告

本报告研究涉及企业/品牌/案例：飞顿医疗激光公司，奇致激光，Lumenis，CANDELA，华西生物，Allergan，昊海生物科技，中国生物兰州生物制品研究所有限责任公司，上海九院，北京八大处，四川华西，小红书，百度，微信，新氧，更美，悦美，美团，阿里健康

当前，中国轻医美市场供需迎来双增长，轻医美市场逐渐崛起。iiMedia Research(艾媒咨询)数据显示，预计2020年中国轻医美市场用户规模将达到1520万人。便捷、安全成轻医美消费重要推力，随着轻医美消费意识日益提升，轻医美或成中国消费者求美的“第一选择”。在消费意识觉醒和消费需求驱动下，机构、医生在供给端强势助推轻医美行业更快速发展。医美机构加速拓展轻医美业务，轻医美诊所应运而生。与此同时，轻医美医生在流程操作、药械使用上更易实现规模化培养。在行业支持体系方面，互联网医美平台助推轻医美加速数字化升级，市场管理提效规范行业发展。在此背景下，中国轻医美消费市场迎来更好的发展空间。纵观当前中国轻医美消费新态势，供需协同并进以及行业支持体系日益完善，轻医美消费已逐渐成为求美新主流。

At present, the supply and demand of China's light medical beauty market is experiencing double growth, and the light medical beauty market is gradually rising. According to iiMedia Research, it is estimated that the user scale of China's light medical beauty market will reach 15.2 million in 2020. Convenience and safety have become an important driving force for the consumption of light medical beauty. With the increasing consumer awareness of light medical beauty, light medical beauty or become the “first choice“ for Chinese consumers seeking beauty. Driven by the awakening of consumer consciousness and consumer demand, institutions and doctors have strongly boosted the rapid development of the light medical beauty industry on the supply side. Medical beauty institutions to accelerate the expansion of light medical beauty business, light medical beauty clinic came into being. At the same time, it is easier for doctors to realize large-scale cultivation in process operation and medical device use. In terms of the industry support system, the Internet medical beauty platform promotes the digitalization and upgrading of medical beauty, and market management improves the efficiency and standardizes the development of the industry. In this context, China's light medical beauty consumer market usher in a better space for development. In view of the new trend of China's light medical beauty consumption, the coordinated development of supply and demand and the increasingly perfect industry support system, light medical beauty consumption has gradually become the new mainstream of seeking beauty.